Concepedia

Author

Amir Kurtaran

University of Vienna

Also Known As

A Kurtaran, A. Kurtaran, Amir Kurtaran, K. Kaczirek,  A Kurtaran

92

Publications

2.2K

Citations

27

H-Index

60

Concepts

All Affiliations

University of ViennaEuropean Association of Nuclear MedicineMedical University of ViennaSeibersdorf Laboratories (Austria)Vienna General Hospital
AK

About

Amir Kurtaran is an author at University of Vienna specializing in medicine, pathology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

16

549

2

Health Sciences

4

4

50

3

Engineering

3

3

125

4

Anatomy

1

1

12

5

Biochemistry

1

1

45

Amir Kurtaran

×

39

Publications

2K

Citations

25

H-Index

YearCitations

Vasoactive Intestinal Peptide-Receptor Imaging for the Localization of Intestinal Adenocarcinomas and Endocrine Tumors

Irene Virgolini, Markus Raderer, Amir Kurtaran,

New England Journal of Medicine

1994

256

Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET.

Alexander Becherer, Monica Szabó, Georgios Karanikas,

PubMed

2004

206

<sup>11</sup>C-Acetate Positron Emission Tomography Imaging and Image Fusion With Computed Tomography and Magnetic Resonance Imaging in Patients With Recurrent Prostate Cancer

Stefan De Wachter, Sandra Tomek, Amir Kurtaran,

Journal of Clinical Oncology

2006

109

FDG-PET in Adrenocortical Carcinoma

Alexander Becherer, H. Vierhapper, Christian Pötzi,

Cancer Biotherapy and Radiopharmaceuticals

2001

100

Indium-111-DOTA-lanreotide: biodistribution, safety and radiation absorbed dose in tumor patients.

Irene Virgolini, I Szilvási, Amir Kurtaran,

PubMed

1998

86

Vasoactive intestinal peptide receptor scintigraphy.

Irene Virgolini, Amir Kurtaran, Markus Raderer,

PubMed

1995

72

Imaging gastrointestinal tumours using vascular endothelial growth factor-165 (VEGF165) receptor scintigraphy

Shuren Li, Markus Peck‐Radosavljevic, Oskar Kienast,

Annals of Oncology

2003

67

Mortality of patients with pulmonary embolism.

Karin Janata, Michael Hölzer, Hans Domanovits,

PubMed

2002

67

Treatment of hepatocellular cancer with the long acting somatostatin analog lanreotide in vitro and in vivo.

Markus Raderer, Michael Hejna, Christian Müller,

International Journal of Oncology

2000

66

Value of Peptide Receptor Scintigraphy Using <sup>123</sup>I-Vasoactive Intestinal Peptide and <sup>111</sup>In-DTPA-D-Phe1-Octreotide in 194 Carcinoid Patients: Vienna University Experience, 1993 to 1998

Markus Raderer, Amir Kurtaran, M. Leimer,

Journal of Clinical Oncology

2000

64

Page 1